A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jack Gilleland
| Share Statistics | CYCN | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $14.6 | $252.6 | 8% |
|
| Shares Out (Mil) | 4.2 | 52.3 | 12% |
|
| Institutional Ownership | 54.0% | 92.1% | 37% |
|
| Float (Mil) | 3.1 | 40.2 | 8% |
|
| Beta | 1.81 | 0.95 | 89% |
|
| Avg Daily Volume (000s) | 18 | 455 | 20% |
|
| Price Change (52-week) |
30.3% | 52.9% | 69% |
|
| Growth | CYCN | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (1.8%) | 13.6% | 13% |
|
| Net Income (5yr) | 46.2% | (9.9%) | 93% |
|
| EPS (5yr) | 53.5% | 16.0% | 94 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 14.9% | (15.6%) | 72% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | CYCN | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2 | $38 | 3% |
|
| Net Income (TTM) (Mil) | ($5) | ($43) | 33% |
|
| EPS (TTM) | ($1.468) | ($1.600) | 18% |
|
| Operating Cash Flow (TTM) (Mil) | ($4) | ($31) | 26% |
|
| Net Cash Flow (TTM) (Mil) | na | $5 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $5 | 0% |
|
| Enterprise Value (Q1) (Mil) | $11 | $180 | 8% |
|
| Valuation | CYCN | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.15 | 2.56 | 53% |
|
| P/E | na | 19.0 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 0.9 | na |
|
| Ratios | CYCN | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 17.1% | 63.8% | 17% |
|
| Net Margin | (264.7%) | (67.3%) | 4% |
|
| ROA | (57.5%) | (49.8%) | 10% |
|
| ROE | (67.8%) | (55.5%) | 13% |
|
| Liabilities to Assets | 20.2% | 30.3% | 13% |
|
| F-Score | 1 | 3 | 1% |
|
Cyclerion Therapeutics, Inc. did not pass any screens on 7/31/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
